News
Two-thirds of UK adults use Traditional Complementary and Integrative Medicine, national survey finds
20 January 2026Icampus 3200 [Full Version]
Revolutionizing Education: The iCampus 3200 Story**
In an era where technology is transforming every aspect of our lives, the education sector is no exception. The introduction of innovative solutions has made it possible for institutions to enhance the learning experience, streamline administrative tasks, and improve student outcomes. One such groundbreaking solution is the iCampus 3200, a cutting-edge platform designed to revolutionize the way we approach education. icampus 3200
In conclusion, the iCampus 3200 is a powerful platform that has the potential to transform the education sector. Its innovative features, user-friendly interface, and robust architecture make it an indispensable tool for educators, students, and administrators. As the education sector continues to evolve, the iCampus 3200 is poised to play a leading role in shaping the future of learning. Revolutionizing Education: The iCampus 3200 Story** In an
As we look to the future, it’s clear that technology will continue to play a vital role in shaping the education sector. The iCampus 3200 is at the forefront of this revolution, providing a platform that is both innovative and effective. With its focus on student engagement, academic performance, and administrative efficiency, the iCampus 3200 is set to become an essential tool for institutions looking to stay ahead of the curve. In conclusion, the iCampus 3200 is a powerful
Hot off the press
A personalized, integrative approach in treating major depressive disorder: N-of-1 study with plasma proteome and physicochemical analysis of homeopathic preparations Open Access
Adler UC, Adler MS, dos Santos Nogueira R et al.
BBI Integrative. 2025; 11: 100133
Full text
Hear from the experts
News
HRI Statement on retraction of Frass et al. 2020 study which found benefits of ‘add-on’ homeopathy for cancer patients undergoing conventional cancer treatment
On 24 November, a clinical trial by Frass et al. 20201 assessing homeopathy provided in addition to usual oncology care in non-small-cell lung carcinoma patients, was retracted by the Editor of the journal. This study, using the gold-standard double-blind placebo-controlled trial design, found that patients receiving additional homeopathic treatment had improved quality of life and increased survival time, compared to the placebo group. More | DE
